Skip to main navigation Skip to search Skip to main content

Cytoplasmic chromatin triggers inflammation in senescence and cancer

  • Zhixun Dou
  • , Kanad Ghosh
  • , Maria Grazia Vizioli
  • , Jiajun Zhu
  • , Payel Sen
  • , Kirk J. Wangensteen
  • , Johayra Simithy
  • , Yemin Lan
  • , Yanping Lin
  • , Zhuo Zhou
  • , Brian C. Capell
  • , Caiyue Xu
  • , Mingang Xu
  • , Julia E. Kieckhaefer
  • , Tianying Jiang
  • , Michal Shoshkes-Carmel
  • , K. M.Ahasan Al Tanim
  • , Glen N. Barber
  • , John T. Seykora
  • , Sarah E. Millar
  • Klaus H. Kaestner, Benjamin A. Garcia, Peter D. Adams, Shelley L. Berger*
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1156 Scopus citations

Abstract

Chromatin is traditionally viewed as a nuclear entity that regulates gene expression and silencing. However, we recently discovered the presence of cytoplasmic chromatin fragments that pinch off from intact nuclei of primary cells during senescence, a form of terminal cell-cycle arrest associated with pro-inflammatory responses. The functional significance of chromatin in the cytoplasm is unclear. Here we show that cytoplasmic chromatin activates the innate immunity cytosolic DNA-sensing cGAS-STING (cyclic GMP-AMP synthase linked to stimulator of interferon genes) pathway, leading both to short-term inflammation to restrain activated oncogenes and to chronic inflammation that associates with tissue destruction and cancer. The cytoplasmic chromatin-cGAS-STING pathway promotes the senescence-associated secretory phenotype in primary human cells and in mice. Mice deficient in STING show impaired immuno-surveillance of oncogenic RAS and reduced tissue inflammation upon ionizing radiation. Furthermore, this pathway is activated in cancer cells, and correlates with pro-inflammatory gene expression in human cancers. Overall, our findings indicate that genomic DNA serves as a reservoir to initiate a pro-inflammatory pathway in the cytoplasm in senescence and cancer. Targeting the cytoplasmic chromatin-mediated pathway may hold promise in treating inflammation-related disorders.

Original languageEnglish
Article number24050
JournalNature
Volume550
Issue number7676
DOIs
StatePublished - 19 Oct 2017
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Cytoplasmic chromatin triggers inflammation in senescence and cancer'. Together they form a unique fingerprint.

Cite this